These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 34202711)

  • 21. A Role for Sigma Receptors in Stimulant Self-Administration and Addiction.
    Katz JL; Hiranita T; Hong WC; Job MO; McCurdy CR
    Handb Exp Pharmacol; 2017; 244():177-218. PubMed ID: 28110353
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heme oxygenase-1 inhibition mediates Gas6 to enhance bortezomib-sensitivity in multiple myeloma via ERK/STAT3 axis.
    Zhang Z; Wang W; Ma D; Xiong J; Kuang X; Zhang S; Fang Q; Wang J
    Aging (Albany NY); 2020 Apr; 12(8):6611-6629. PubMed ID: 32298237
    [TBL] [Abstract][Full Text] [Related]  

  • 23. How does binding of imidazole-based inhibitors to heme oxygenase-1 influence their conformation? Insights combining crystal structures and molecular modelling.
    Carletta A; Tilborg A; Moineaux L; de Ruyck J; Basile L; Salerno L; Romeo G; Wouters J; Guccione S
    Acta Crystallogr B Struct Sci Cryst Eng Mater; 2015 Aug; 71(Pt 4):447-54. PubMed ID: 26208625
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of danthron as an isoform-specific inhibitor of HEME OXYGENASE-1/cytochrome P450 reductase interaction with anti-tumor activity.
    Chou YT; Hsu FF; Hu DY; Chen YC; Hsu YH; Hsu JT; Chau LY
    J Biomed Sci; 2018 Jan; 25(1):6. PubMed ID: 29361943
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Isoflavone ME-344 Disrupts Redox Homeostasis and Mitochondrial Function by Targeting Heme Oxygenase 1.
    Zhang L; Zhang J; Ye Z; Manevich Y; Ball LE; Bethard JR; Jiang YL; Broome AM; Dalton AC; Wang GY; Townsend DM; Tew KD
    Cancer Res; 2019 Aug; 79(16):4072-4085. PubMed ID: 31227482
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of heme oxygenase-1 with an epidermal growth factor receptor inhibitor and cisplatin decreases proliferation of lung cancer A549 cells.
    Kuroda H; Takeno M; Murakami S; Miyazawa N; Kaneko T; Ishigatsubo Y
    Lung Cancer; 2010 Jan; 67(1):31-6. PubMed ID: 19375813
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Discovery of SI 1/20 and SI 1/22 as Mutual Prodrugs of 5-Fluorouracil and Imidazole-Based Heme Oxygenase 1 Inhibitor with Improved Cytotoxicity in DU145 Prostate Cancer Cells.
    Salerno L; Sorrenti V; Pittalà V; Consoli V; Modica MN; Romeo G; Marrazzo A; Giuliano M; Zajdel P; Vanella L; Intagliata S
    ChemMedChem; 2023 Apr; 18(8):e202300047. PubMed ID: 36756924
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combined inhibition of Hsp90 and heme oxygenase-1 induces apoptosis and endoplasmic reticulum stress in melanoma.
    Barbagallo I; Parenti R; Zappalà A; Vanella L; Tibullo D; Pepe F; Onni T; Li Volti G
    Acta Histochem; 2015 Oct; 117(8):705-11. PubMed ID: 26493719
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel Structural Insight into Inhibitors of Heme Oxygenase-1 (HO-1) by New Imidazole-Based Compounds: Biochemical and In Vitro Anticancer Activity Evaluation.
    Greish KF; Salerno L; Al Zahrani R; Amata E; Modica MN; Romeo G; Marrazzo A; Prezzavento O; Sorrenti V; Rescifina A; Floresta G; Intagliata S; Pittalà V
    Molecules; 2018 May; 23(5):. PubMed ID: 29783634
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeting heme Oxygenase-1 with hybrid compounds to overcome Imatinib resistance in chronic myeloid leukemia cell lines.
    Sorrenti V; Pittalà V; Romeo G; Amata E; Dichiara M; Marrazzo A; Turnaturi R; Prezzavento O; Barbagallo I; Vanella L; Rescifina A; Floresta G; Tibullo D; Di Raimondo F; Intagliata S; Salerno L
    Eur J Med Chem; 2018 Oct; 158():937-950. PubMed ID: 30261468
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Heme oxygenase-1 inhibits rat and human breast cancer cell proliferation: mutual cross inhibition with indoleamine 2,3-dioxygenase.
    Hill M; Pereira V; Chauveau C; Zagani R; Remy S; Tesson L; Mazal D; Ubillos L; Brion R; Asghar K; Mashreghi MF; Kotsch K; Moffett J; Doebis C; Seifert M; Boczkowski J; Osinaga E; Anegon I
    FASEB J; 2005 Dec; 19(14):1957-68. PubMed ID: 16319139
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Engineered Polymeric Micelles for Combinational Oxidation Anticancer Therapy through Concurrent HO-1 Inhibition and ROS Generation.
    Noh J; Jung E; Lee J; Hyun H; Hong S; Lee D
    Biomacromolecules; 2019 Feb; 20(2):1109-1117. PubMed ID: 30605610
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of heme oxygenase-1 enhances the chemosensitivity of laryngeal squamous cell cancer Hep-2 cells to cisplatin.
    Lv X; Song DM; Niu YH; Wang BS
    Apoptosis; 2016 Apr; 21(4):489-501. PubMed ID: 26801320
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of tumor growth and alteration of associated macrophage cell type by an HO-1 inhibitor in breast carcinoma-bearing mice.
    Deng R; Wang SM; Yin T; Ye TH; Shen GB; Li L; Zhao JY; Sang YX; Duan XG; Wei YQ
    Oncol Res; 2013; 20(10):473-82. PubMed ID: 24308158
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recombinant truncated and microsomal heme oxygenase-1 and -2: differential sensitivity to inhibitors.
    Vukomanovic D; McLaughlin B; Rahman MN; Vlahakis JZ; Roman G; Dercho RA; Kinobe RT; Hum M; Brien JF; Jia Z; Szarek WA; Nakatsu K
    Can J Physiol Pharmacol; 2010 Apr; 88(4):480-6. PubMed ID: 20555417
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Induction of heme oxygenase-1 with hemin alleviates cisplatin-induced reproductive toxicity in male rats and enhances its cytotoxicity in prostate cancer cell line.
    Heeba GH; Hamza AA; Hassanin SO
    Toxicol Lett; 2016 Dec; 264():38-50. PubMed ID: 27815112
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel experimental heme oxygenase-1-targeted therapy for hormone-refractory prostate cancer.
    Alaoui-Jamali MA; Bismar TA; Gupta A; Szarek WA; Su J; Song W; Xu Y; Xu B; Liu G; Vlahakis JZ; Roman G; Jiao J; Schipper HM
    Cancer Res; 2009 Oct; 69(20):8017-24. PubMed ID: 19808972
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Progress in the development of selective heme oxygenase-1 inhibitors and their potential therapeutic application.
    Salerno L; Floresta G; Ciaffaglione V; Gentile D; Margani F; Turnaturi R; Rescifina A; Pittalà V
    Eur J Med Chem; 2019 Apr; 167():439-453. PubMed ID: 30784878
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of heme oxygenase activity using a microparticle formulation of zinc protoporphyrin in an acute hemolytic newborn mouse model.
    Fujioka K; Kalish F; Wong RJ; Stevenson DK
    Pediatr Res; 2016 Feb; 79(2):251-7. PubMed ID: 26488552
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protoporphyrin IX tracer fluorescence modulation for improved brain tumor cell lines visualization.
    Piffaretti D; Burgio F; Thelen M; Kaelin-Lang A; Paganetti P; Reinert M; D'Angelo ML
    J Photochem Photobiol B; 2019 Dec; 201():111640. PubMed ID: 31734545
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.